Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Acuity Brands | AYI | 18. oct 2024 | 307.55 | +0.32 |
Acumen Pharmaceuticals | ABOS | 18. oct 2024 | 2.86 | +7.52 |
Acurx Pharmaceuticals | ACXP | 18. oct 2024 | 2.01 | -0.50 |
Acushnet | GOLF | 18. oct 2024 | 62.30 | -3.46 |
ACV Auctions A | ACVA | 18. oct 2024 | 19.05 | -0.78 |
ACWI Ex-US Index MSCI Ishares | ACWX | 18. oct 2024 | 56.40 | +0.75 |
ACWI Index MSCI Ishares | ACWI | 18. oct 2024 | 120.65 | +0.58 |
Adagene ADR | ADAG | 18. oct 2024 | 2.61 | +8.30 |
Adagio Medical | ADGM | 18. oct 2024 | 2.80 | 0.00 |
Adams Diversified Equity Fund | ADX | 18. oct 2024 | 21.92 | +0.27 |
Adams Natural Resources Fund | PEO | 18. oct 2024 | 23.99 | +0.13 |
Adams Resources & Energy | AE | 18. oct 2024 | 26.25 | -1.06 |
AdaptHealth | AHCO | 18. oct 2024 | 11.00 | +1.57 |
Adaptimmune Therapeutics ADR | ADAP | 18. oct 2024 | 0.84 | +0.14 |
Adaptive Biotechnologies | ADPT | 18. oct 2024 | 4.68 | +0.86 |
ADC Therapeutics SA | ADCT | 18. oct 2024 | 3.12 | -0.64 |
Addentax Group | ATXG | 18. oct 2024 | 0.70 | +0.72 |
Addex Therapeutics ADR | ADXN | 18. oct 2024 | 10.44 | -1.51 |
Addus HomeCare | ADUS | 18. oct 2024 | 131.81 | -0.90 |
Adecoagro | AGRO | 18. oct 2024 | 11.38 | -0.09 |
Adeia | ADEA | 18. oct 2024 | 12.44 | -0.24 |
Adial Pharmaceuticals | ADIL | 18. oct 2024 | 1.01 | +4.11 |
Adicet Bio | ACET | 18. oct 2024 | 1.45 | -2.03 |
Adient | ADNT | 18. oct 2024 | 22.75 | +4.21 |
Aditxt | ADTX | 18. oct 2024 | 1.05 | -2.78 |
Adlai Nortye | ANL | 18. oct 2024 | 1.95 | 0.00 |
ADMA Biologics | ADMA | 18. oct 2024 | 15.78 | -2.11 |
Adobe | ADBE | 18. oct 2024 | 494.90 | -0.39 |
ADS-TEC | ADSE | 18. oct 2024 | 14.01 | -4.50 |
ADT | ADT | 18. oct 2024 | 7.09 | +1.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.